Phase II-III study evaluating the effectiveness and safety of sublingual immunotherapy in patients with birch pollen allergy.

Supported projects > Other Supported Projects by EU · 2023

Authors: Özlem GÖKSEL

2023-2025, Other Supported Projects by EU , R & D Project, Continues

View details